The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail


AbbVie Deutschland GmbH & Co. KGEU/1/12/801/001-004

Main Information

Trade NameConstella
Active SubstancesLinaclotide
Dosage FormCapsule, hard
Licence HolderAbbVie Deutschland GmbH & Co. KG
Licence NumberEU/1/12/801/001-004

Group Information

ATC CodeA06AX Other drugs for constipation
A06AX04 linaclotide


License statusAuthorised
Licence Issued26/11/2012
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusUnknown


Summary of Product CharacteristicsSearch EMA website
Package LeafletSearch EMA website
Public Assessment ReportSearch EMA website
« Back